These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Expression of c-myc, erbB-2, p53 and nm23-H1 gene product in benign and malignant breast lesions: coexpression and correlation with clinicopathologic parameters. Sirotkovic-Skerlev M; Krizanac S; Kapitanovic S; Husnjak K; Unusic J; Pavelic K Exp Mol Pathol; 2005 Aug; 79(1):42-50. PubMed ID: 16005711 [TBL] [Abstract][Full Text] [Related]
43. Evaluation of combined h-TERT, bcl-2, and caspases 3 and 8 expression in cutaneous malignant melanoma based on tissue microarrays and computerized image analysis. Zygouris P; Tsiambas E; Tiniakos D; Karameris A; Athanassiou AE; Kittas Ch; Kyroudi A J BUON; 2007; 12(4):513-9. PubMed ID: 18067210 [TBL] [Abstract][Full Text] [Related]
44. Nuclear survivin is associated with disease recurrence and poor survival in patients with cutaneous malignant melanoma. Piras F; Murtas D; Minerba L; Ugalde J; Floris C; Maxia C; Colombari R; Perra MT; Sirigu P Histopathology; 2007 Jun; 50(7):835-42. PubMed ID: 17543072 [TBL] [Abstract][Full Text] [Related]
45. Expression of nm23 antimetastatic gene product in parathyroid hyperplasia, adenoma and carcinoma. An immunohistological assessment. Al-Maghrabi JA; Asa SL Saudi Med J; 2005 May; 26(5):728-31. PubMed ID: 15951858 [TBL] [Abstract][Full Text] [Related]
46. Correlation of Ki-67 expression in cutaneous primary melanoma with prognosis in a prospective study: different correlation according to thickness. Moretti S; Spallanzani A; Chiarugi A; Fabiani M; Pinzi C J Am Acad Dermatol; 2001 Feb; 44(2):188-92. PubMed ID: 11174375 [TBL] [Abstract][Full Text] [Related]
47. Expression of metastasis suppressor gene product, nm23 protein, is not inversely correlated with the tumour progression in human malignant melanomas. Saitoh K; Takahashi H; Yamamoto M; Kishi H; Parsons PG Histopathology; 1996 Dec; 29(6):497-505. PubMed ID: 8971556 [TBL] [Abstract][Full Text] [Related]
48. [Expression of nm23 protein and estrogen receptor and prognosis of colorectal cancers]. Qin Z; Wan D; Lian J; Lin H; Hou J Zhonghua Wai Ke Za Zhi; 2000 Jul; 38(7):514-6. PubMed ID: 11832096 [TBL] [Abstract][Full Text] [Related]
49. Increased expression of integrin-linked kinase is correlated with melanoma progression and poor patient survival. Dai DL; Makretsov N; Campos EI; Huang C; Zhou Y; Huntsman D; Martinka M; Li G Clin Cancer Res; 2003 Oct; 9(12):4409-14. PubMed ID: 14555513 [TBL] [Abstract][Full Text] [Related]
50. Ki-67 and p53 expression in minimal deviation melanomas as compared with other nevomelanocytic lesions. Chorny JA; Barr RJ; Kyshtoobayeva A; Jakowatz J; Reed RJ Mod Pathol; 2003 Jun; 16(6):525-9. PubMed ID: 12808056 [TBL] [Abstract][Full Text] [Related]
51. An immunohistochemical analysis of nm23 gene product expression in uveal melanoma. Greco IM; Calvisi G; Ventura L; Cerrito F Melanoma Res; 1997 Jun; 7(3):231-6. PubMed ID: 9195562 [TBL] [Abstract][Full Text] [Related]
52. Clinical and histopathological risk factors to predict sentinel lymph node positivity, disease-free and overall survival in clinical stages I-II AJCC skin melanoma: outcome analysis from a single-institution prospectively collected database. MandalĂ M; Imberti GL; Piazzalunga D; Belfiglio M; Labianca R; Barberis M; Marchesi L; Poletti P; Bonomi L; Novellino L; Di Biagio K; Milesi A; Guerra U; Tondini C Eur J Cancer; 2009 Sep; 45(14):2537-45. PubMed ID: 19553103 [TBL] [Abstract][Full Text] [Related]
53. Tumor characteristics involved in the metastatic behaviour as an improvement in primary cutaneous melanoma prognostics. Goldmann T; Ribbert D; Suter L; Brode M; Otto F J Exp Clin Cancer Res; 1998 Dec; 17(4):483-9. PubMed ID: 10089072 [TBL] [Abstract][Full Text] [Related]
54. Expression of nm23 protein in adult soft tissue sarcoma is correlated with histological grade. D'Souza RJ; Sheikh ZA; Busund LT; Russell PJ; Crowe PJ; Yang JL Anticancer Res; 2003; 23(4):3289-94. PubMed ID: 12926065 [TBL] [Abstract][Full Text] [Related]
55. [Expression of P53 protein in cutaneous melanoma]. Casazza S; Gambini C; Tunesi G; Rovida S; Caruso F; Pastorino A; Canepa M Pathologica; 1993; 85(1097):335-42. PubMed ID: 8233650 [TBL] [Abstract][Full Text] [Related]
56. CD44v6 and Nm23-H1 protein expression related to clinico pathological parameters in colorectal cancer. Messinetti S; Giacomelli L; Fabrizio G; Giarnieri E; Gabatel R; Manno A; Feroci D; Guerriero G; Masci E; Vecchione A Ann Ital Chir; 2003; 74(1):45-51. PubMed ID: 12870281 [TBL] [Abstract][Full Text] [Related]
57. Novel role for RGS1 in melanoma progression. Rangel J; Nosrati M; Leong SP; Haqq C; Miller JR; Sagebiel RW; Kashani-Sabet M Am J Surg Pathol; 2008 Aug; 32(8):1207-12. PubMed ID: 18580492 [TBL] [Abstract][Full Text] [Related]
58. Prognostic significance of nuclear ING3 expression in human cutaneous melanoma. Wang Y; Dai DL; Martinka M; Li G Clin Cancer Res; 2007 Jul; 13(14):4111-6. PubMed ID: 17634537 [TBL] [Abstract][Full Text] [Related]
59. Utility of tumour-infiltrating CD25+FOXP3+ regulatory T cell evaluation in predicting local recurrence in vertical growth phase cutaneous melanoma. Miracco C; Mourmouras V; Biagioli M; Rubegni P; Mannucci S; Monciatti I; Cosci E; Tosi P; Luzi P Oncol Rep; 2007 Nov; 18(5):1115-22. PubMed ID: 17914561 [TBL] [Abstract][Full Text] [Related]